GlobalData’s report assesses the drugs in the Alpha Synuclein pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
The NIH has found evidence of research misconduct against Eliezer Masliah, M.D., the longtime head of the National Institute ...
A question and answer session with Prof Suzanne Timmons, Professor of Geriatric Medicine at University College Cork ...
Annovis Bio saw promising results for Buntanetap in treating Alzheimer's and Parkinson's, but short cash runway prompts a ...
Tel Aviv University-led team uses super-resolution microscopy to detect abnormal aggregates in skin cells, focusing on 2 gene ...
One of the major breakthroughs over the last couple of years has been a potential new diagnostic test for Parkinson’s – a ...
Researchers at the Jan and Dan Duncan Neurological Research Institute (NRI) at Texas Children's Hospital and Baylor College ...
ATH434 shows promise as a disease-modifying therapy for MSA -- ATH434-202 Phase 2 interim data demonstrate stabilization of clinical symptoms ...
Andrew Fein, an analyst from H.C. Wainwright, maintained the Buy rating on Prothena (PRTA – Research Report). The associated price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback